Enanta Pharmaceuticals, Inc.
NASDAQ:ENTABiotechnology
Healthcare
$8.23 -0.67%
-$0.09 today
- Market cap
- $239.70M
- Beta
- 0.99
- P/E (TTM)
- -4.3
- EPS (TTM)
- -$2.90
52W Low $6.44High $17.15
Volume 0.81M
Average 0.17M
Price history
Enanta Pharmaceuticals, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-33.41%
Period high
$16.85
Period low
$8.23
Latest
$8.23
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 8-K | Oct 29, 2026 | Oct 29, 2026 | |
| 8-K | Oct 28, 2026 | Oct 28, 2026 | |
| SC 13G | Oct 27, 2026 | Oct 27, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| 10-Q | Aug 12, 2026 | Aug 12, 2026 | |
| 8-K | Aug 10, 2026 | Aug 10, 2026 | |
| 4 | Aug 10, 2026 | Aug 10, 2026 | |
| 424B5 | Jul 2, 2026 | Jul 2, 2026 | |
| 8-K | Jul 2, 2026 | Jul 2, 2026 | |
| 8-K | Jun 23, 2026 | Jun 23, 2026 | |
| 8-K | Jun 18, 2026 | Jun 18, 2026 | |
| 10-Q | May 13, 2026 | May 13, 2026 | |
| S-8 | May 13, 2026 | May 13, 2026 | |
| 8-K | May 11, 2026 | May 11, 2026 |
Competitors
Who does Enanta Pharmaceuticals, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about ENTA's filings, answered from its disclosures.
What is the latest ENTA filing?
The latest filing shown is 8-K dated Oct 29, 2026.
How many recent filings does ENTA have?
Intrinsic Alpha currently shows 20 recent filings for ENTA.
Continue the stock analysis
Jump to another research area for this company.